OR

Browse By

A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer (MRFF EPCDR administered by Griffith). (2020–2024)

Grant type:
Griffith University
Researchers:

  • Professor Andreas Obermair

    NHMRC Leadership Fellow
    UQ Centre for Clinical Research
    Faculty of Medicine

  • Professor Monika Janda

    Centre Director
    Centre for Health Services Research
    Faculty of Medicine
    Centre Director
    Faculty of Medicine
    Centre Director of Centre for Healt
    Centre for Health Services Research
    Faculty of Medicine
Funded by:
Griffith University